Newsletter Subject

Daily Headlines: Sham Knee Surgery as Good as the Real Thing?

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, May 30, 2017 11:09 AM

Email Preheader Text

Daily Headlines May 30, 2017 CME/CE Additional Resources Industry Resources [Official Physicians' Si

Daily Headlines May 30, 2017 [Sham Knee Surgery as Good as the Real Thing?]( [Healthcare Seen Highly Vulnerable to Cyberattack]( [A Patient's Journey: Support Group for Prostate Cancer Patients?]( [AAP: Group Decisions Benefit Kids With Disabilities]( [CMSC: Chemo Drug Offers Durable Effects in MS]( CME/CE Additional Resources [Diagnosis and Treatment of Relapsed Myeloma]( [AML: Beware of Pre-leukemic Clones Surviving Chemotherapy]( [Support for Omitting ALND in Early Breast Cancer]( Industry Resources [Site For Endocrinologists Low Testosterone Due To Certain Medical Conditions. Treatment Info]( [Renal Cancer Treatment - Official HCP Site A Once-Daily Oral Treatment For Advanced Renal Cell Carcinoma Patients]( [Official Physicians' Site ERBITUX® (cetuximab) View Boxed Warning, Safety & Prescribing Info]( Recent Headlines [The Importance of Being Honest]( [CMSC: New MS Drug Maintains Superiority in OPERA Analysis]( CME/CE [Can We Lower Drug Costs?]( [CMSC: PPAR-Gamma Drug Shows Promise for MS]( CME/CE [PodMed: A Medical News Roundup From Johns Hopkins]( ADVERTISEMENT This Week's Survey [Are the Voluntarily Uninsured Just Freeloaders?]( [Some have argued that the]([sharp rise in the uninsured population]( expected under the AHCA simply represents a free choice not to buy health insurance. But doctors and hospitals will inevitably have to provide unpaid care for many of them. CME Spotlights [Can your pharmacist substitute your biologic? Is that OK?]( [Source: France Foundation]( [Playing The Offense In Advanced Basal Cell Carcinoma: A Team Approach To Treatment And Management]( [Source: RMEI Medical Education]( [Breast Cancer @POC w/Watson]( [Source: @Point of Care]( [MDS and Acute Myeloid Leukemia (MDS and AML) @Point of Care]( [Source: @Point of Care]( [Skin Cancers @Point of Care]( [Source: @Point of Care]( [Clinical Context:Gynecological Cancers Case Studies1]( [Source: Projects in Knowledge, Inc.]( [Clinical Context:Gynecological Cancers CaseStudies4]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Multiple Myeloma CaseStudies1]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Multiple Myeloma CaseStudies2]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Prostate Cancer CaseStudies1]( [Source: Projects In Knowledge, Inc.]( [Clinical Context:Prostate Cancer CaseStudies2]( [Source: Projects In Knowledge, Inc.]( [A Patient-Centric, Performance Measures-Based Approach to NSCLC]( [Source: RMEI Medical Education]( [Neurology Mastery in Multiple Sclerosis Case Studies 1]( [Source: Projects In Knowledge, Inc.]( [Outcomes in NSCLC: A Focus on Quality Improvement-Part1]( [Source: RMEI Medical Education]( More of Today's Stories [Valbenazine for Tardive Dyskinesia Tolerated Long-Term]( [CMSC: Anti-CD20 Tx Offers Rapid B-Cell Depletion in MS Patients]( CME/CE [CMSC: New MS Drug Maintains Superiority in OPERA Analysis]( CME/CE [Medicare Fraud Conviction for Retina Surgeon]( [Spondylarthropathies Boost Risk for Cardiovascular Events]( CME/CE [Syrian Refugee Children Have High Burden of Anxiety]( [Reducing ER Discharge Times: (HealthLeaders Media)]( [The Importance of Being Honest]( [Can Some MS Patients Stop Disease-Modifying Drugs?]( CME/CE [Can We Lower Drug Costs?]( [CMSC: PPAR-Gamma Drug Shows Promise for MS]( CME/CE [PodMed: A Medical News Roundup From Johns Hopkins]( [CMSC: When It's Not MS]( CME/CE [D.C. Week: CBO Still Sees Surge in Uninsured with AHCA]( [Ebola Outbreak in Congo Not as Large as Feared]( [Does Spicy Food Increase Aggression? That's Improbable!]( [A Patient's Journey: Me and My 'Lame' Cancer]( [RA Mobile Apps Meeting Some Needs, Missing the Mark on Others]( More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. © 2017 Medpage Today, LLC. All rights reserved. Use of this site constitutes acceptance of the [MedPageToday.com]( [terms of use]( and [privacy policy](. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Medpage Today is located at 345 Hudson Street, New York, NY 10014 [Remove me from this list](lst=Daily%20Headlines) [Manage my e-mail settings](

Marketing emails from medpagetoday.com

View More
Sent On

30/06/2024

Sent On

30/06/2024

Sent On

29/06/2024

Sent On

29/06/2024

Sent On

28/06/2024

Sent On

28/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.